Lataa...
Sarcoidosis extent relates to molecular variability
The molecular basis of sarcoidosis phenotype heterogeneity and its relationship to effective treatment of sarcoidosis have not been elucidated. Peripheral samples from sarcoidosis subjects who participated in a Phase II study of golimumab [anti‐tumour necrosis factor (TNF)‐α] and ustekinumab [anti‐i...
Tallennettuna:
| Julkaisussa: | Clin Exp Immunol |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5422855/ https://ncbi.nlm.nih.gov/pubmed/28205212 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.12942 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|